Epigral Limited has informed the Exchange regarding Board meeting held on November 10, 2025.Outcome of Board Meeting held on Monday, 10th November, 2025 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended on 30th September, 2025.
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited's Board of Directors met on November 10, 2025, and approved the unaudited financial results (both standalone and consolidated) for the second quarter and half year ended September 30, 2025. The results have been submitted to the stock exchanges. The detailed financial figures were not included in this intimation filing and would be available in the separately filed results document.
This is a routine regulatory filing confirming the approval and submission of quarterly results. Shareholders should review the detailed results document for actual revenue, profit, and margin figures to assess the company's performance for the quarter.